Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
by on Wednesday, September 14th, 2011 | No Comments
Conditions: Breast Cancer; Heart Failure
Interventions: Drug: Metoprolol; Drug: Placebo; Drug: Candesartan; Drug: Placebo
Sponsors: University Hospital, Akershus; University of Oslo; Norwegian Cancer Society; AstraZeneca
Recruiting – verified September 2011
Follow this link: Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy